No drug-related tumors were observed up to 75 mg/kg or approximately 32 times the maximum recommended clinical dose of 25 mg, based on area under the plasma concentration curve (AUC) exposure
We dig into: Lilly's decision to stop disclosing its Phase 1 pipeline The Camurus fluid crystal technology deal and what it means for long-acting GLP-1s Eloralintide Lilly's selective amylin agonist and potential dark horse in obesity medicine How eloralintide compares to Novo Nordisk's cagrilintide Why the future of obesity treatment is a toolbox, not a scoreboard The access crisis: prior authorizations, insurance exclusions, Medicare, and Medicaid coverage gaps Retatrutide , quintuple agonists, and what's coming out of ADA 2026 If you're on Zepbound , Wegovy , Ozempic , or any GLP-1 medication or you're waiting for the next generation of obesity drugs this episode is for you
Each day, it requires you to log in to the app and complete 3 things: Weigh in Take a quiz / do a lesson Log your food and exercise Thats it
Weight loss drugs such as Mounjaro offer huge potential to tackle soaring obesity globally but are currently only available to one in 10 of those who need them, the World Health Organization has said
It is important to re the best lip balm for chapped lips after looking through my Lippie collection I realized how many lip balms I have and which ones I tend to always reach for, and which ones I never really use was so obvious